Kai W Wucherpfennig

30PUBLICATIONS
296CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 09, 2026
The CARM1 epigenetic enzyme inhibits cross-presenting dendritic cell function in cancer immunity.

|May 20, 2026
Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancer.

|May 15, 2026
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial.

|Mar 13, 2026
Multimodal framework for the joint analysis of single-cell RNA and T cell receptor sequencing data predicts T cell response to cancer immunotherapy.

Chujun He, Matthew Amodio, Orr Ashenberg

|Aug 01, 2025
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities.

Anne Knisely, Yibo Dai, Graham L Barlow

|Jan 17, 2025
Selective deficiency of mitochondrial respiratory complex I subunits Ndufs4/6 causes tumor immunogenicity.

Jiaxin Liang, Tevis Vitale, Xixi Zhang

Pageof 5

Frequent Collaborators

5 joint publications

Lucas Ferrari de Andrade

4 joint publications

Mario L Suvà

4 joint publications

Nathan D Mathewson

4 joint publications

Jason W Pyrdol